Ratings Zhejiang Jolly Pharmaceutical Co.,LTD




End-of-day quote Shenzhen S.E. 18:00:00 2024-06-16 EDT 5-day change 1st Jan Change
15.9 CNY +3.11% Intraday chart for Zhejiang Jolly Pharmaceutical Co.,LTD +1.60% +49.16%


  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company's profit outlook over the next few years is a strong asset.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.


  • In relation to the value of its tangible assets, the company's valuation appears relatively high.

Ratings chart - Surperformance

Investor Rating
Trading Rating
ESG Refinitiv


Sales growth
Earnings Growth
EBITDA / Sales


P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow


1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision


Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 300181 Stock
  4. Ratings Zhejiang Jolly Pharmaceutical Co.,LTD